Connor Clark & Lunn Investment Management Ltd. Acquires 20,026 Shares of Harvard Bioscience, Inc. (NASDAQ:HBIO)
Connor Clark & Lunn Investment Management Ltd. raised its holdings in shares of Harvard Bioscience, Inc. (NASDAQ:HBIO – Free Report) by 11.1% in the 4th quarter, HoldingsChannel.com reports. The fund owned 200,032 shares of the medical instruments supplier’s stock after purchasing an additional 20,026 shares during the quarter. Connor Clark & Lunn Investment Management Ltd.’s […]
